Immunogenicity profile after COVID-19 vaccination in patients with onco-hematological diseases

Abstract

Neto et al. demonstrated that patients with oncohematological diseases can achieve satisfactory levels of specific COVID-19 immunoglobulin G antibodies after vaccination, particularly if there was previous exposure to the infection, but the underlying disease's etiological group and treatment history may influence this response.